✦ LIBER ✦

Efficacy and safety of prolonged 3-year telbivudine treatment in patients with chronic hepatitis B

✍ Scribed by Edward J. Gane; Yuming Wang; Yun-Fan Liaw; JinLin Hou; Satawat Thongsawat; MoBin Wan; Young M. Moon; JiDong Jia; You C. Chao; Junqi Niu; Nancy Leung; Didier Samuel; Chao Wei Hsu; Weibin Bao; Patricia Lopez; Claudio Avila

Book ID: 111239507
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 212 KB
Volume: 31
Category: Article
ISSN: 0106-9543
DOI: 10.1111/j.1478-3231.2011.02490.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of switching to telbivudine in

Efficacy of switching to telbivudine in chronic hepatitis B patients treated previously with lamivudine

✍ Rifaat Safadi; Qing Xie; Yagang Chen; You-Kuan Yin; Lai Wei; Seong Gyu Hwang; El 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 202 KB

Kinetics of hepatitis B surface antigen

Kinetics of hepatitis B surface antigen decline during 3 years of telbivudine treatment in hepatitis B e antigen–positive patients

✍ Karsten Wursthorn; Mechthild Jung; Antonio Riva; Zachary D. Goodman; Patricia Lo 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 565 KB

Four years of lamivudine treatment in Ch

Four years of lamivudine treatment in Chinese patients with chronic hepatitis B

✍ TING-TSUNG CHANG; CHING-LUNG LAI; RONG-NAN CHIEN; RICHARD GUAN; SENG-GEE LIM; CH 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB

Treatment of chronic hepatitis B with te

Treatment of chronic hepatitis B with telbivudine: wise hepatologists needed in hepatitis B endemic countries where treatment options are limited

✍ Cihan Yurdaydin; Ulus S. Akarca 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB

Efficacy of prolonged interferon-alpha t

Efficacy of prolonged interferon-alpha treatment in chronic hepatitis B patients with HBeAb: comparison between 6 and 12 months of therapy

✍ J. M. Lopez-Alcorocho; J. Bartolome; T. Cotonat; V. Carreño 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 567 KB

Telbivudine versus lamivudine in Chinese

Telbivudine versus lamivudine in Chinese patients with chronic hepatitis B: Results at 1 year of a randomized, double-blind trial

✍ Jinlin Hou; You-Kuan Yin; Daozhen Xu; Deming Tan; Junqi Niu; Xiaqiu Zhou; Yuming 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB

Chronic hepatitis B and its life-threatening sequelae are highly prevalent in China. There is a need for effective new therapies to suppress hepatitis B virus (HBV) replication and ameliorate liver disease. In this study, we compared the efficacy of telbivudine, a nucleoside analogue, with lamivudin